BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4204394)

  • 1. [Kinetics of bacterial destruction rate as a prognostic indicator in the treatment of tuberculous patients with tuberculostatics].
    Sheri I
    Probl Tuberk; 1973; 51(11):74-8. PubMed ID: 4204394
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognostic value of isolation of drug-resistant Mycobacterium tuberculosis].
    Astionenko AA
    Vrach Delo; 1978 Dec; (12):27-30. PubMed ID: 105475
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis treated in the santorium in Abastumani].
    Shilakadze EM; Margadze GKh; Zautashvili MG
    Probl Tuberk; 1975; (3):79. PubMed ID: 124432
    [No Abstract]   [Full Text] [Related]  

  • 4. [Resistance to antitubercular agents in patients with pulmonary tuberculosis treated in the period from 1967 to 1970].
    Marsenić B; Panajotović H
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():60-7. PubMed ID: 4216923
    [No Abstract]   [Full Text] [Related]  

  • 5. [Resistance of Mycobacterium tuberculosis to the major antitubercular drugs in pulmonary tuberculosis in children and youth previously untreated].
    Mordyński K; Piotrowski Z; Szymański A
    Gruzlica; 1968 Aug; 36(8):715-8. PubMed ID: 4972465
    [No Abstract]   [Full Text] [Related]  

  • 6. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug resistance of Mycobacterium tuberculosis. Behavior of the phenomenon during the past 10 years].
    Daddi G; Lucchesi M; Maldarizzi B; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1969; 29(4):286-300. PubMed ID: 5004328
    [No Abstract]   [Full Text] [Related]  

  • 8. [Frequency and clinical importance of primary pharmacoresistance of Mycobacteria in patients with tuberculosis of the lungs].
    Bibik NF
    Probl Tuberk; 1972; 50(8):20-5. PubMed ID: 4626690
    [No Abstract]   [Full Text] [Related]  

  • 9. [Advances in the treatment of pulmonary tuberculosis in children].
    Alcaide Megias J; Altet Gómez MN
    An Esp Pediatr; 1983 Sep; 19 Suppl 19():12-7. PubMed ID: 6419658
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical research: course of pulmonary tuberculosis caused by polyresistant Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P
    Ann Ist Carlo Forlanini; 1969; 29(4):330-8. PubMed ID: 5004331
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H; Maekawa N; Nakanishi M; Kawai M; Naito M
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary drug resistant tuberculosis in Puerto Rico.
    Zack MB; Figueroa-Lebrón RE
    Bol Asoc Med P R; 1974 Nov; 65(11):262-6. PubMed ID: 4217187
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of new antitubercular agents--new quinolones].
    Kawahara S; Eirei J
    Kekkaku; 1992 Oct; 67(10):679-82. PubMed ID: 1453572
    [No Abstract]   [Full Text] [Related]  

  • 14. Difficulties in the diagnosis and treatment of drug-resistant tuberculosis and tuberculous empyema.
    Glisson J; Mehta JB
    J Tenn Med Assoc; 1992 Sep; 85(9):419-22. PubMed ID: 1405623
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary resistance in the area of the District of Split].
    Giunio N
    Plucne Bolesti; 1986; 38(2):144-6. PubMed ID: 3097689
    [No Abstract]   [Full Text] [Related]  

  • 16. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. 2].
    Yamamoto M
    Kekkaku; 1970 Nov; 45(11):359-66. PubMed ID: 4992936
    [No Abstract]   [Full Text] [Related]  

  • 17. [Resistance problems in Mycobacteria tuberculosis and the treatment of severe tuberculosis with secondary antitubercular agents].
    Vojtek J; Holecková R; Rozánek R; Starosta V; Strnad M; Sebests J; Strusa V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1965; 8(5):589-92. PubMed ID: 4955225
    [No Abstract]   [Full Text] [Related]  

  • 18. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM
    Probl Tuberk; 1974; (10):1-6. PubMed ID: 4213757
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ethambutol in the treatment of chronic pulmonary tuberculosis with bacilli resistant to tuberculostatics].
    Anastasatu C; Kaufman S; Barcan F; Gheorghiu M; Cristea M; Ulpian C; Iancovici O
    Ftiziologia; 1971; 20(4):373-9. PubMed ID: 5005706
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary chemoresistance to tuberculostatics in the district of Dolj between the years 1971 and 1975].
    Golli V; Tufescu R; Ciobanu C; Zaharia P; Bălaşa-Clotîrnoiu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1978; 23(1):37-42. PubMed ID: 418488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.